Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
When I bowl I sweat that's why I chalk my finger and air dry each time I score I high five my buddys when I drink in a bar I leave saliva residue on my glass do I need to list all possible areas in which another person could possibly touch the sweat or other unknown fluid an ebola infected person They don't have a clue how big this will become but it's here and increasing That's a Fact
PEOPLE HAVE NO IDEA HOW BIG A PROBLEM THIS WILL BECOME EBOLA IN NYC
They're getting off their A$$#$ FIRE FLY DX PSID HERE WE GO$$$$$
http://bioprepwatch.com/biological-threats/dhs-to-host-outbreak-management-webinar/339762/
The program, titled “Detecting and Monitoring Disease and Illness Outbreaks: Data Sources and Systems for Public Health and Emergency Management Officials,” aims to improve the handling of disease outbreaks.
You need to watch again
Next generation FIREFLY detects Ebola in 10 min.
http://www.foxbusiness.com/on-air/willis-report/videos#p/157870/v/3841659343001
Blood in the water sharks will come
You seem desperate...Wonder how long has it taken to develop a cure for Ebola?? How about the time it takes to detect it?
Answer FIREFLY DX updated version LESS THAN 10 MIN.
Psid and Ensco partnership can give us an edge on this crisis and stop it with desnse deployment to detect and contain Ebola or any other threats.
http://www.ensco.com/products-services/security-products/microsearch.htm
Some areas in which deployment of FIRE FLY DX most likely will be rolled out
http://www.ensco.com/about-ensco/contract-vehicles.htm
July 17, 2014
Time line :July 17, 2014
PositiveID Receives New Order to Support M-BAND System for U.S. Government Contract
Order Increases the Value of Existing Department of Defense Contract; PositiveID Increases Revenue/Backlog Estimate to $3.5 Million; Reiterates Revenue Guidance of $4-10 Million Through the End of 2015
DELRAY BEACH, Fla., July 17, 2014 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCQB:PSID), a developer of biological detection and diagnostics solutions, today announced that it has received a new order from a large government contractor for the continued testing and evaluation of PositiveID's M-BAND (Microfluidic Bioagent Autonomous Networked Detector) in support of an existing U.S. government contract. In keeping with contractual obligations the contractor and program have not been named. As a result of this new purchase order, the company has increased its 2014/2015 revenue and backlog (backlog added to revenue recognized) estimate from $3.3 million to $3.5 million, and is reiterating its revenue guidance of $4-10 million through the end of 2015 (2014 and 2015 combined).
"We view this latest purchase order as another validation of not only our technical capabilities, but also our ability to collaborate with large commercial and government partners, while continuing to execute our strategy," stated William J. Caragol, Chairman and CEO of PositiveID. "We are very pleased to continue the testing of our M-BAND units to protect our nation's warfighters and defenders."
October 10, 2014
PositiveID Corporation and ENSCO Awarded Contract for U.S. Department of Homeland Security SenseNet Program
PositiveID Will Offer Its Firefly Dx System Under the SenseNet Program for Faster, Less Expensive Bio-Threat Detection
DELRAY BEACH, Fla., Oct. 10, 2014 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID") (OTCQB:PSID), a developer of biological detection and diagnostics solutions, today announced that it, in conjunction with its partner, ENSCO, Inc., has been awarded a SenseNet Program contract from the U.S. Department of the Interior on behalf of the U.S. Department of Homeland Security Science & Technology Directorate. The goal of this SenseNet award is to implement faster, less expensive bio-threat detection systems, using existing infrastructure where possible, to provide an added level of security.
As part of this award, PositiveID will offer its Firefly Dx system, which is a point-of-need system designed to deliver molecular diagnostic results using real-time PCR (polymerase chain reaction) chemistry. Firefly is designed to derive results from a sample in less than 20 minutes at the point of sampling, compared to two to four hours for a lab device, which would enable accurate diagnostics leading to more rapid and effective treatment than what is currently available with existing systems, helping to save lives. ENSCO will be responsible for the systems integration and decision support.
"We are pleased to work with ENSCO on this effort for the Department of Homeland Security's SenseNet program," stated William J. Caragol, Chairman and CEO of PositiveID. "We believe our Firefly Dx system, coupled with ENSCO's systems expertise, can provide an ideal solution for the biological detection capabilities that DHS is pursuing."
ENSCO, Inc.
ENSCO, Inc., and its wholly owned subsidiaries represent a $90 million technology enterprise, headquartered in the Washington, D.C., area. For more than 45 years, the ENSCO group of companies has been providing ingenious engineering, science and advanced technology solutions that guarantee mission success, safety and security to governments and private industries around the globe. ENSCO operates in the defense, transportation, aerospace and intelligence sectors. Field offices and subsidiaries, representatives and partnerships are located throughout the United States and around the world. www.ensco.com
PositiveID Corporation
PositiveID Corporation is an emerging growth company and developer of biological detection systems for America's homeland defense industry as well as rapid biological testing. PositiveID is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats at high-value locations, as well as analyze samples in a medical environment. For more information on PositiveID, please visit http://www.PositiveIDCorp.com.
bet ya if it's going to 0000000000000000
Why did the Congress and White House sat on Their A$$#$ while the national security of the threat of a Bio- Hazard as Ebola Is raging till now to get any Dense Deployment of MBand and Fire Fly
How do you come to that conclusion which company will have a product For the U.S. Govt with all it's red tape and hoops to jump over to come to market get approval, gain partnerships, signed contracts, test and re-test, and have it to deliver before Psid Mband and FireFly DX
Name the company my friend...I'll dump all my shares in a heartbeat on PSID.
Governments to Spend Billions for Best Security Devices
The world remains a dangerous place. While a sense of complacency tends to permeate the discussion, there will always be bad folks and bad weapons that can do us harm. Analogous to treating deadly diseases, the key to homeland security is early and accurate detection.
According to Homeland Security Research Corp. ("HSRC"), the annual global bio-detection market is forecast to grow to $5.6 billion by 2016, a compound annual growth rate ("CAGR") of 12% from 2011. The U.S. market is expected to reach $2.6 billion by 2016, doubling its market from 2010.
Investors should make no mistake; these are massive government and commercial markets that are actively seeking to acquire the latest, most robust, cost-effective solutions to the greatest global security and health threats.
That's where PositiveID (OTCQB:PSID) comes in. The Company is entirely focused on homeland defense, with two exciting technologies and several high-profile government and commercial partners.
The Company is on a roll. In just the past six weeks, the biological detection and diagnostics company has announced contracts with NASA, Leidos/Department of Defense, and UTC Aerospace Systems. Investors may also recall that the Company has received $2.5 million from Boeing and $30 million in contract funding from the U.S. Department of Homeland Security Science and Technology Directorate. Based on Company's ability to execute and the opportunities ahead, this may only be the beginning for PSID.
"In the near future, chemical weapon attacks, as we recently saw in Syria, could be detected early and mitigated, saving countless lives," stated William J. Caragol, Chairman and Chief Executive Officer of PositiveID, in an exclusive interview with Financial Press. "As a leader in biological and diagnostic solutions, PositiveID's M-BAND (Microfluidic Bioagent Autonomous Networked Detector), which was developed with $30 million of contract funding from DHS, and Firefly products are positioned to capitalize on the next generation of BioWatch; the U.S. government's $3-$5 billion program to detect the release of pathogens into the air as part of a defense against potential terrorist attacks on major American cities."
In a research report by Taglich Brothers, the firm rates PSID a Speculative Buy with a 12-month target of $0.16, roughly double the current share price. Analyst Howard Halpern refers to the U.S. government's next generation of BioWatch, which represents a $3 billion opportunity. He further explains that as the subcontractor to its licensing partner Boeing, PSID is expected to supply proprietary assays and reagents for Boeing's implementation of M-BAND automated pathogen detection units. He estimates at least 875 M-BAND units could be deployed by 2020, and cites the revenue potential for the Company as "substantial."
Once successfully implemented, the next generation of BioWatch will detect airborne pathogens, warning government and public health authorities of a potential bio-terror threat such as anthrax, ricin, bacteria, etc.
Developed countries continue to advance their approach to the early detection of biological agents and prevention of outbreaks of disease. The key to the success of these programs lies in the proliferation of cost-effective, third generation bio-detection technologies—such as M-BAND— resulting in a significantly shortened response time to bioterror attacks.
For a small company, PSID is being supported and advanced on some very big shoulders. Boeing paid PositiveID $2.5 million for the right to become the exclusive distributor of M-BAND for BioWatch. On May 5, 2014, the Company announced an agreement with NASA to collaborate on testing the Company's Firefly Dx detection system ("Firefly") as a platform for biological research and commercial development for ground and space applications. The Company intends to partner with NASA to market the technology to Government agencies, with the validation by NASA through its own testing and direct access to potential government agencies being the salient selling points.
In less than 20 minutes, as opposed to hours, the self-sufficient handheld Firefly device — pretty much a portable version of M-BAND – will deliver rapid and accurate point-of-need diagnostics that will enable hospitals, first responders, and other providers to save lives. Much as the larger M-BAND unit, Firefly can quickly detect biological agents associated with weapons of mass destruction. As well, in the diagnostic realm, Firefly will be capable of processing a variety of sample types, including whole blood, buccal and nasopharyngeal swabs, urine, and environmental field samples. The incorporated, multiplex PCR assay will be able to analyze for multiple, user-defined targets from a single sample.
While the science is complex, the applications are not and should be extremely compelling to investors. M-BAND, basically a bio-aerosol monitor, works autonomously indoors or out for a 30-day period, constantly monitoring the air for bacteria, toxins and viruses. Within 40-120 minutes, depending on the bio-threat detected, the unit will report over a secure wireless network. The small footprint, cost-effective unit adds a much higher level of security in the detection of the very diseases deployed by natural occurrence, or more importantly, deadly diseases and substances unleashed by our enemies.
M-BAND currently performs high specificity detection for six biological organisms and four toxins on the Centers for Disease Control's category A and B select agents list, and is configurable to detect up to 20 biological organisms.
The Company holds a portfolio of over 20 key patents/patents pending primarily for the automation of biological detection using real-time analysis for the rapid, reliable and specific identification of pathogens.
M-BAND is expected to rollout in 2015-2016. Firefly will get to prototype stage in 2015.
Caragol states: "In 2014, PSID has seen and followed up on five government applications for M-BAND and Firefly. Importantly three to five are in collaboration with four different and extremely large commercial/government customer. The Company made a recent announcement of an award of a five-year, potentially $4 billion by the U.S. Defense Threat Reduction Agency (DTRA) for research into weapons of mass destruction detection to our teaming partner Leidos, a Fortune 500 constituent."
PositiveID trades at $0.08 with a market cap of $5.63 million.
Legal Disclaimer/Disclosure: A fee has been paid for the production and distribution of this Report. This document is not and should not be construed as an offer to sell or the solicitation of an offer to purchase or subscribe for any investment. No information in this article should be construed as individualized investment advice. A licensed financial advisor should be consulted prior to making any investment decision. Financial Press makes no guarantee, representation or warranty and accepts no responsibility or liability as to its accuracy or completeness. Expressions of opinion are those of the author's only and are subject to change without notice. Financial Press assumes no warranty, liability or guarantee for the current relevance, correctness or completeness of any information provided within this article and will not be held liable for the consequence of reliance upon any opinion or statement contained herein or any omission. Furthermore, we assume no liability for any direct or indirect loss or damage or, in particular, for lost profit, which you may incur as a result of the use and existence of the information, provided within this article.
Also, please note that republishing of this article in its entirety is permitted as long as attribution and a back link to FinancialPress.com are provided. Thank you.
The Ebola play is just getting started my friend
October 2014 – AFRICA – At 3:30 a.m. in the world’s biggest Ebola treatment center, Daniel Lucey found the outbreak reduced to its essentials: patients lying on mattresses on the floor and vomiting in the dark, visible only by the wavering flashlight beam of a single volunteer doctor. “I don’t see a light at the end of the tunnel,” said Lucey, a physician and professor from Georgetown University who is halfway through a five-week tour in Liberia with Medecins Sans Frontieres, the medical charity known in English as Doctors Without Borders. “The epidemic is still getting worse,” he said by phone between shifts. That’s an increasingly urgent challenge for MSF and the global health community. As fear spreads in the U.S. over transmission of the virus to two nurses in a modern Dallas hospital, the main fight against the outbreak is still being waged by volunteers like Lucey half a world away.
MSF has been the first — and often only — line of defense against Ebola in West Africa. The group raised the alarm on March 31, months ahead of the World Health Organization. Now, after treating almost a third of the roughly 9,000 confirmed Ebola cases in Africa — and faced with a WHO warning of perhaps 10,000 new infections a week by December — MSF is reaching its limits. “They are at the breaking point,” said Vinh-Kim Nguyen, a professor at the School of Public Health at the University of Montreal who has volunteered for a West African tour with MSF in a few weeks. MSF has already seen 21 workers infected and 12 people die, and “there’s a sense that there’s a major wave of infections that’s about to wash everything away,” Nguyen said. –Bloomberg
October 2014 – FREETOWN, Sierra Leone — After emerging months ago in eastern Sierra Leone, Ebola is now hitting the western edges of the country where the capital is located with dozens of people falling sick each day, the government said Tuesday. So many people are dying that removing bodies is reportedly a problem. Forty-nine confirmed cases of Ebola emerged in just one day, Monday, in two Ebola zones in and around the capital, the National Ebola Response Center, or NERC, said. Lawmaker Claude Kamanda who represents a western area said more than 20 deaths are being reported daily. Kamanda told the local Politico newspaper that authorities are experiencing challenges collecting corpses from both quarantined and non-quarantined homes. Authorities say the uncontrolled movement of people from the interior to Waterloo which is the gateway to Freetown, the capital, has fueled the increase of Ebola cases in the west. There is a strong feeling that people are violating the quarantines elsewhere and coming to Freetown through Waterloo.
There are 851 total confirmed Ebola cases in the two zones, called Western Area Urban and Western Area Rural, the NERC said. In numbers of cases, they may soon surpass a former epicenter of the outbreak in the country, the eastern districts of Kenema and Kailahun where there have been a total of 1,012 confirmed cases. No new cases were reported Monday in Kenema and Kailahun but a World Health Organization spokeswoman said it is too early to declare that the epidemic has burned itself out in the east. “There was a drop in new cases in Kenema and Kailahun and fingers were crossed but there has been a bit of a flare up thanks to a couple of unsafe burials,” said Margaret Harris, WHO’s spokeswoman in Sierra Leone. “So it’s too early to say we have a real decline … definitely too early to say it’s been beaten there.” A local newspaper suggested Tuesday that authorities quarantine Waterloo. The World Food Program over the weekend delivered emergency food rations to people there.
“The growing fear has left the public with no choice but to call on the Government for Waterloo to be quarantined as was done to other places including Kailahun, Kenema, Bombali, Port Loko and Moyamba Districts,” the Exclusive newspaper said. Many residents of the capital note that Ebola has followed the same route across the country as rebels who in 1991 started a savage war in Kailahun district. The war ended in Freetown a decade later where the final battle was fought. Now the enemy is a disease, and the president is putting in place a more military-style response. President Ernest Bai Koroma last week appointed Defense Minister Alfred Palo Conteh as CEO of the National Ebola Response Center, whose headquarters are being placed at the former War Crimes Tribunal for Sierra Leone in the west end of Freetown together with the United Nations Mission for Ebola Emergency Response.
The west African nations of Sierra Leone, Liberia and Guinea — where the outbreak first emerged 10 months ago — have been hit hard by Ebola with more than 4,500 deaths, according to WHO estimates. A few cases have also emerged in the United States and Spain, and on Tuesday the east African nation of Rwanda was singling out travelers from the U.S. and Spain for special screening. A Rwandan Ministry of Health document says all passengers from the U.S. and Spain will have their temperatures taken upon arrival. If the passenger has a fever he or she is denied entry. If there is no fever, the visitors still must report their health condition daily to authorities. The U.S. Embassy in Rwanda on Tuesday urged Americans who may have a fever or who have traveled to Ebola countries “to weigh carefully whether travel to Rwanda at this time is prudent.” –HP
MRIB only way to make money here is to short this .IMO this is 0000
This is the most troubling of all news ...why we need to detect and contain this virus on all fronts .If the virus gets into the wrong hands imagine the problems this could have Fire Fly Dx is point of need detection for it, as well as other harmful pathogens.. DHS and DOD is scrambling....
http://news.yahoo.com/ebola-families-bodies-bribes-153423993.html
How is this going to stop a terrorist
http://www.foxbusiness.com/on-air/money-with-melissa-francis/index.html#/v/3830700649001
Understand the bigger picture of PSID
http://video.foxnews.com/v/3850069099001/could-ebola-be-used-as-a-weapon-of-terror/#sp=show-clips
Cut The Bull@##@ PSID has more coming news soon and Is a takeover target and Needs to to fill orders for business expansion opportunities
at this time, the increase in authorized shares of common stock is not in any way related to any plans or intentions to enter into a merger, consolidation, acquisition or similar business transaction.
Further, there are certain advantages and disadvantages of an increase in our authorized stock. The advantages include, among others, the ability to raise capital by issuing capital stock under the transactions described above, or other financing transactions, and to have shares of our capital stock available to pursue business expansion opportunities, if any. The disadvantages include, among others, the issuance of additional shares of our capital stock could be used to deter a potential takeover of us that may otherwise be beneficial to stockholders by diluting the shares held by a potential suitor or issuing shares to a stockholder that will vote in accordance with our Board’s desires. A takeover may be beneficial to independent stockholders because, among other reasons, a potential suitor may offer such stockholders a premium for their shares of stock compared to the then-existing market price. We do not have any plans or proposals to adopt provisions or enter into agreements that may have material anti-takeover consequences. In addition, shareholders do not have any preemptive or similar rights to subscribe for or purchase any additional shares of common stock that may be issued in the future and, therefore, future issuances of common stock may, depending on the circumstances, have a dilutive effect on the earnings per share, voting power and other interests of our existing shareholders.
Why PSID is not an Ebola Play ....Ebola crisis proved to the Govt It needed to get it's act together on securing the nation against such Bio Threats... DHS and DOD has been preparing for such threats for awhile however when Ebola became as reality they saw how ill-prepared they were ..Now to shore up the defense on threats such as ebola or whatever next they have to act NOW.. Ebola IS NOW..and they drop the ball.. however there is good news they are scrambling to get to fix the problem Mband...FIREFLY DX are all being rolled out next few months we'll see our nation with a faster more robust system in place even if Ebola ever should raise it's head or other unknown threats this nation will be ready.
Looks like filled is confirmed!!!!!52 week high next stop PSID rock$$$$$$$$
Looks like we're filled!!!!!!!!!!
Gap has to be filled and then GOOOOOOOOOOO!!!!!
Governments to Spend Billions for Best Security Devices
The world remains a dangerous place. While a sense of complacency tends to permeate the discussion, there will always be bad folks and bad weapons that can do us harm. Analogous to treating deadly diseases, the key to homeland security is early and accurate detection.
According to Homeland Security Research Corp. ("HSRC"), the annual global bio-detection market is forecast to grow to $5.6 billion by 2016, a compound annual growth rate ("CAGR") of 12% from 2011. The U.S. market is expected to reach $2.6 billion by 2016, doubling its market from 2010.
Investors should make no mistake; these are massive government and commercial markets that are actively seeking to acquire the latest, most robust, cost-effective solutions to the greatest global security and health threats.
That's where PositiveID (OTCQB:PSID) comes in. The Company is entirely focused on homeland defense, with two exciting technologies and several high-profile government and commercial partners.
The Company is on a roll. In just the past six weeks, the biological detection and diagnostics company has announced contracts with NASA, Leidos/Department of Defense, and UTC Aerospace Systems. Investors may also recall that the Company has received $2.5 million from Boeing and $30 million in contract funding from the U.S. Department of Homeland Security Science and Technology Directorate. Based on Company's ability to execute and the opportunities ahead, this may only be the beginning for PSID.
"In the near future, chemical weapon attacks, as we recently saw in Syria, could be detected early and mitigated, saving countless lives," stated William J. Caragol, Chairman and Chief Executive Officer of PositiveID, in an exclusive interview with Financial Press. "As a leader in biological and diagnostic solutions, PositiveID's M-BAND (Microfluidic Bioagent Autonomous Networked Detector), which was developed with $30 million of contract funding from DHS, and Firefly products are positioned to capitalize on the next generation of BioWatch; the U.S. government's $3-$5 billion program to detect the release of pathogens into the air as part of a defense against potential terrorist attacks on major American cities."
In a research report by Taglich Brothers, the firm rates PSID a Speculative Buy with a 12-month target of $0.16, roughly double the current share price. Analyst Howard Halpern refers to the U.S. government's next generation of BioWatch, which represents a $3 billion opportunity. He further explains that as the subcontractor to its licensing partner Boeing, PSID is expected to supply proprietary assays and reagents for Boeing's implementation of M-BAND automated pathogen detection units. He estimates at least 875 M-BAND units could be deployed by 2020, and cites the revenue potential for the Company as "substantial."
Once successfully implemented, the next generation of BioWatch will detect airborne pathogens, warning government and public health authorities of a potential bio-terror threat such as anthrax, ricin, bacteria, etc.
Developed countries continue to advance their approach to the early detection of biological agents and prevention of outbreaks of disease. The key to the success of these programs lies in the proliferation of cost-effective, third generation bio-detection technologies—such as M-BAND— resulting in a significantly shortened response time to bioterror attacks.
For a small company, PSID is being supported and advanced on some very big shoulders. Boeing paid PositiveID $2.5 million for the right to become the exclusive distributor of M-BAND for BioWatch. On May 5, 2014, the Company announced an agreement with NASA to collaborate on testing the Company's Firefly Dx detection system ("Firefly") as a platform for biological research and commercial development for ground and space applications. The Company intends to partner with NASA to market the technology to Government agencies, with the validation by NASA through its own testing and direct access to potential government agencies being the salient selling points.
In less than 20 minutes, as opposed to hours, the self-sufficient handheld Firefly device — pretty much a portable version of M-BAND – will deliver rapid and accurate point-of-need diagnostics that will enable hospitals, first responders, and other providers to save lives. Much as the larger M-BAND unit, Firefly can quickly detect biological agents associated with weapons of mass destruction. As well, in the diagnostic realm, Firefly will be capable of processing a variety of sample types, including whole blood, buccal and nasopharyngeal swabs, urine, and environmental field samples. The incorporated, multiplex PCR assay will be able to analyze for multiple, user-defined targets from a single sample.
While the science is complex, the applications are not and should be extremely compelling to investors. M-BAND, basically a bio-aerosol monitor, works autonomously indoors or out for a 30-day period, constantly monitoring the air for bacteria, toxins and viruses. Within 40-120 minutes, depending on the bio-threat detected, the unit will report over a secure wireless network. The small footprint, cost-effective unit adds a much higher level of security in the detection of the very diseases deployed by natural occurrence, or more importantly, deadly diseases and substances unleashed by our enemies.
M-BAND currently performs high specificity detection for six biological organisms and four toxins on the Centers for Disease Control's category A and B select agents list, and is configurable to detect up to 20 biological organisms.
The Company holds a portfolio of over 20 key patents/patents pending primarily for the automation of biological detection using real-time analysis for the rapid, reliable and specific identification of pathogens.
M-BAND is expected to rollout in 2015-2016. Firefly will get to prototype stage in 2015.
Caragol states: "In 2014, PSID has seen and followed up on five government applications for M-BAND and Firefly. Importantly three to five are in collaboration with four different and extremely large commercial/government customer. The Company made a recent announcement of an award of a five-year, potentially $4 billion by the U.S. Defense Threat Reduction Agency (DTRA) for research into weapons of mass destruction detection to our teaming partner Leidos, a Fortune 500 constituent."
PositiveID trades at $0.08 with a market cap of $5.63 million.
Legal Disclaimer/Disclosure: A fee has been paid for the production and distribution of this Report. This document is not and should not be construed as an offer to sell or the solicitation of an offer to purchase or subscribe for any investment. No information in this article should be construed as individualized investment advice. A licensed financial advisor should be consulted prior to making any investment decision. Financial Press makes no guarantee, representation or warranty and accepts no responsibility or liability as to its accuracy or completeness. Expressions of opinion are those of the author's only and are subject to change without notice. Financial Press assumes no warranty, liability or guarantee for the current relevance, correctness or completeness of any information provided within this article and will not be held liable for the consequence of reliance upon any opinion or statement contained herein or any omission. Furthermore, we assume no liability for any direct or indirect loss or damage or, in particular, for lost profit, which you may incur as a result of the use and existence of the information, provided within this article.
Also, please note that republishing of this article in its entirety is permitted as long as attribution and a back link to FinancialPress.com are provided. Thank you.
Thanks for posting heard of the interview never saw it
"We have been in contact with the Govt for quite sometime"
Since the Ebola crisis hit the U.S. wonder what calls PSID got...
EXPLOSIVE NEWS SOOOOOON$$$$$$$$$
Did Ebola crisis moved up the price tag? Anyhow 3 billion ,5 billion what the heck it's still BILLIONS$$$$$$$$$$$$$
July 25, 2012
PositiveID Corporation Adds Chief Technology Advisor and Biodefense Expert as It Prepares for $3.1 Billion BioWatch Procurement
With the ebola crisis here and now exposed Congress and the White House and CDC how Ill Prepared The U.S. and the world was to handle the current crisis now the scramble to implement the safety net not only to protect from Ebola but other Threats PSID day has arrived
BILLIONS I repeat BILLIONS is this
Gap And Gone$$$$$$$$$$
PSID fast tracked$$$$$$
http://www.bioworld.com/content/fda-grants-emergency-use-authorization-ebola-assay-0
The DoD's Ebola Zaire Target 1 real-time polymerase chain reaction assay – one of the Taqman series of assays – can be run on several analyzers,
Contract inked with Ensco The goal of this SenseNet award is to implement faster, less expensive bio-threat detection systems, using existing infrastructure where possible, to provide an added level of security.
As part of this award, PositiveID will offer its Firefly Dx system, which is a point-of-need system designed to deliver molecular diagnostic results using real-time PCR (polymerase chain reaction) chemistry. Firefly is designed to derive results from a sample in less than 20 minutes at the point of sampling, compared to two to four hours for a lab device, which would enable accurate diagnostics leading to more rapid and effective treatment than what is currently available with existing systems, helping to save lives. ENSCO will be responsible for the systems integration and decision support.
he outbreak drove the U.S. Centers for Disease Control and Prevention to post a level 1 alert after health care providers in Nigeria diagnosed a patient with the disease. The outbreak has also sparked coverage of FDA's review of treatments for Ebola, but diagnostics makers are scrambling to leverage their assets, including PositiveID, of Delray Beach, Fla., which is touting the firm's handheld Firefly DX, another Taqman PCR system, as a potentially valuable tool in constraining the spread of Ebola.
Investors should make no mistake; these are massive government and commercial markets that are actively seeking to acquire the latest, most robust, cost-effective solutions to the greatest global security and health threats.
That's where PositiveID (OTCQB:PSID) comes in. The Company is entirely focused on homeland defense, with two exciting technologies and several high-profile government and commercial partners.
The Company is on a roll. In just the past six weeks, the biological detection and diagnostics company has announced contracts with NASA, Leidos/Department of Defense, and UTC Aerospace Systems. Investors may also recall that the Company has received $2.5 million from Boeing and $30 million in contract funding from the U.S. Department of Homeland Security Science and Technology Directorate. Based on Company's ability to execute and the opportunities ahead, this may only be the beginning for PSID.
Question if a offer was made for your share right now what would you take?
Put a lock on your shares this will blow$$$$$$You'll not be able to catch it.
Additionally, at this time, the increase in authorized shares of common stock is not in any way related to any plans or intentions to enter into a merger, consolidation, acquisition or similar business transaction.
Further, there are certain advantages and disadvantages of an increase in our authorized stock. The advantages include, among others, the ability to raise capital by issuing capital stock under the transactions described above, or other financing transactions, and to have shares of our capital stock available to pursue business expansion opportunities, if any. The disadvantages include, among others, the issuance of additional shares of our capital stock could be used to deter a potential takeover of us that may otherwise be beneficial to stockholders by diluting the shares held by a potential suitor or issuing shares to a stockholder that will vote in accordance with our Board’s desires. A takeover may be beneficial to independent stockholders because, among other reasons, a potential suitor may offer such stockholders a premium for their shares of stock compared to the then-existing market price. We do not have any plans or proposals to adopt provisions or enter into agreements that may have material anti-takeover consequences. In addition, shareholders do not have any preemptive or similar rights to subscribe for or purchase any additional shares of common stock that may be issued in the future and, therefore, future issuances of common stock may, depending on the circumstances, have a dilutive effect on the earnings per share, voting power and other interests of our existing shareholders.
Gap up and will be gone too many big players are coming on board no games to play Ive talked to some of those in my circle and "EVERYONE" has mentioned PSID is in the cross hairs...EBOLA calls for IMMEDIATE actions or the consequences will threaten the WORLD"S INFRASTRUCTURE ...FIREFLY ...as well as other protocols put in place, can give GOVT a chance against the virus or in the future of any unknowns that may appear.
PSID Firefly DX #2 detects virus 10 min. on point of need by it's hand held device now in use, with latest developments with ebola DHS, DOD, CDC and WHO has urged for quick deployment...accordingly Ensco has been contracted to rollout a "DENSE DEPLOYMENT" of FIREFLY DX due to the spread of the virus.
Not day trading this one it'll gap up and never catch it
Don't play it'll cost you they're lined up to take your shares from you
Back on line and blast off
Call your brokers lock down your shares
Folks again Hold and lock up your shares this will blow how high we have no idea yet but I'm long and keep adding .
http://globalbiodefense.com/2014/10/16/federal-contracts-roundup-oct-16-2014/
DHS Award for SenseNet Biodetection Program PositiveID Corporation in conjunction with its partner, ENSCO, Inc., has been awarded a SenseNet Program contract from the U.S. Department of the Interior on behalf of the U.S. Department of Homeland Security Science & Technology Directorate. The goal of this SenseNet award is to implement faster, less expensive bio-threat detection systems, using existing infrastructure where possible, to provide an added level of security. As part of this award, PositiveID will offer its Firefly Dx system, which is a point-of-need system designed to deliver molecular diagnostic results using real-time PCR (polymerase chain reaction) chemistry. Firefly is designed to derive results from a sample in less than 20 minutes at the point of sampling. ENSCO will be responsible for the systems integration and decision support. - See more at: http://globalbiodefense.com/2014/10/16/federal-contracts-roundup-oct-16-2014/#sthash.StcrXuFy.dpuf
It's going to get worse...Detect and contain the virus FIREFLY DX NEEDED
http://www.foxnews.com/health/2014/10/17/dallas-lab-worker-quarantined-aboard-cruise-ship-other-passengers-stranded/
could you please post the link of the Sean Hannity or the transcript Thanks in advance.
Due to disclosure agreements you can under why vagueness is important, however Dr Luciana Borio stated yesterday before congress in not to many words that they're doing everything
to enable access to the use of an Ebola diagnostic test that was under development by the Department of Defense (DOD)and to deploy